Why the study?
Does pioglitazone improve lipoprotein metabolism in patients with type 2 diabetes mellitus?
Population
Patients with type 2 diabetes mellitus (T2DM)
Design
Other
Authors
Loading...
May support TG lowering in T2DM; leaves open effects on cardiovascular outcomes in trials.
Does pioglitazone improve lipoprotein metabolism in patients with type 2 diabetes mellitus?
Pioglitazone lowers VLDL triglycerides in type 2 diabetes by enhancing LPL-mediated lipolysis and reducing apoC-III production.
Nagashima et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: